Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention — PASTCDI  

CDI Clinical Trial

Official title: Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention

Status Completed

Clinical Trial Summary

To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.

Clinical Trial Description

This study aims to use a pre/post implementation design to evaluate the use of a novel risk classification tool to improve existing methods of identifying patients eligible for routine antimicrobial stewardship (AMS) care processes targeting reduction of Clostridioides difficile infection (CDI). Antimicrobial stewardship is an established, evidence-based quality improvement program that is required by The Joint Commission and a condition of participation by the Centers for Medicare and Medicaid. AMS processes of care are evidence based, supported by published research demonstrating outcomes benefits, are recommended by national guidelines and are not investigational. Treatment decisions remain at the discretion of clinicians and patients ;

Related Conditions & MeSH terms

• CDI

• NCT number: NCT05508607
• Study type: Observational
• Source: Intermountain Health Care, Inc.
• Status: Completed
• Start date: May 1, 2021
• Completion date: June 30, 2022